Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients. - Wikidata - awgldk - TriplyDB

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients.

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients.

http://www.wikidata.org/entity/Q35138635

about

Prevalence of human papillomavirus cervical infection in an Italian asymptomatic population Systematic reviews and meta-analyses of the accuracy of HPV tests, visual inspection with acetic acid, cytology, and colposcopy Current Cervical Carcinoma Screening Guidelines Clinical Practice Guidelines on the Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention in Saudi Arabia Knowledge of Patients' Human Papillomavirus Status at the Time of Cytologic Review Significantly Affects the Performance of Cervical Cytology in the ATHENA Study.Comparison between the Hybrid Capture II test and a PCR-based human papillomavirus detection method for diagnosis and posttreatment follow-up of cervical intraepithelial neoplasia.SMARCB1(INI1)-deficient sinonasal basaloid carcinoma: a novel member of the expanding family of SMARCB1-deficient neoplasms.Predictive Value of Class III D Cytological Diagnosis (Munich II, Low and Moderate Dysplasia) and Additional High-risk HPV Testing.Psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: cross sectional questionnaire study Use of cervicovaginal fluid for the identification of biomarkers for pathologies of the female genital tract.Presence of E6 and E7 mRNA from human papillomavirus types 16, 18, 31, 33, and 45 in the majority of cervical carcinomas.Prevalence of high-risk HPV types and associated genital diseases in women born in 1988/89 or 1983/84--results of WOLVES, a population-based epidemiological study in Wolfsburg, Germany.Annual Papanicolaou screening for 5 years among human papillomavirus-negative women Comparison of clinical and analytical performance of the Abbott Realtime High Risk HPV test to the performance of hybrid capture 2 in population-based cervical cancer screening.Cross-sectional comparison of an automated hybrid capture 2 assay and the consensus GP5+/6+ PCR method in a population-based cervical screening program.Incidence patterns and temporal trends of invasive nonmelanotic vulvar tumors in Germany 1999-2011. A population-based cancer registry analysis Comparison of the hybrid capture 2 and cobas 4800 tests for detection of high-risk human papillomavirus in specimens collected in PreservCyt medium.Primary screening for human papillomavirus compared with cytology screening for cervical cancer in European settings: cost effectiveness analysis based on a Dutch microsimulation model.Complementary procedures in cervical cancer screening in low resource settings Head-to-Head Comparison of the RNA-Based Aptima Human Papillomavirus (HPV) Assay and the DNA-Based Hybrid Capture 2 HPV Test in a Routine Screening Population of Women Aged 30 to 60 Years in Germany.HPV-DNA testing for cervical cancer precursors: from evidence to clinical practice Clinical relevance of human papillomavirus testing in cytopathology.Study-based evaluation of the Abbott RealTime High Risk HPV test in comparison to the HC2 HR HPV test in women aged ≥30 years using residual LBC ThinPrep specimens.Relevance of HPV Screening for Triaging Equivocal Cytology Findings in the Pap II-p, Pap III and Pap IIID Groups - Results of Two Long-Term Studies Visual inspection of cervix with Lugol's iodine for early detection of premalignant & malignant lesions of cervix.Laboratory and clinical aspects of human papillomavirus testing Optimizing technology for cervical cancer screening in high-resource settings.The probability for a Pap test to be abnormal is directly proportional to HPV viral load: results from a Swiss study comparing HPV testing and liquid-based cytology to detect cervical cancer precursors in 13,842 women.The psychological impact of human papillomavirus testing in women with borderline or mildly dyskaryotic cervical smear test results: 6-month follow-up.HPV DNA testing for cervical cancer screening. FIGO 26th Annual Report on the Results of Treatment in Gynecological Cancer.Negative human papillomavirus testing in normal smears selects a population at low risk for developing high-grade cervical lesions.Cervical screening in the 21st century: the case for human papillomavirus testing of self-collected specimens.Practice guidelines for the early detection of cervical cancer in Korea: Korean Society of Gynecologic Oncology and the Korean Society for Cytopathology 2012 edition.Cost-effectiveness of primarily human papillomavirus-based cervical cancer screening in settings with currently established Pap screening: a systematic review commissioned by the German Federal Ministry of Health.Long term predictive values of cytology and human papillomavirus testing in cervical cancer screening: joint European cohort study Early detection of cervical carcinomas: finding an overall approach Variability of high risk HPV genotypes among HIV infected women in Mwanza, Tanzania- the need for evaluation of current vaccine effectiveness in developing countries.Performance of human papillomavirus DNA and mRNA testing strategies for women with and without cervical neoplasia Clinical performance of human papillomavirus E6 and E7 mRNA testing for high-grade lesions of the cervix.Human papillomavirus type 26 infection causing multiple invasive squamous cell carcinomas of the fingernails in an AIDS patient under highly active antiretroviral therapy

P2860

Q24816786-347608F2-6608-4FDD-8939-F9AF6D3B2D6D Q26768543-C4457BB7-EA95-42AA-82EB-32867CD0CA96 Q26799522-2605E435-A37D-4A51-801C-3915E642144B Q28076573-399EA6A1-EEE8-46CE-B7BF-D25C92360056 Q30276085-804041C0-5840-42CB-8DFC-319AD82BB15E Q33885141-41CBF8C7-67BC-43B8-91C3-5F872DB45300 Q34078980-0D186E74-10D0-4C7B-99BB-51E36FD2E146 Q34209621-2C1BD741-7309-4DDF-939E-1E46FAB15D9B Q34363171-7FDE5C36-909C-4010-8190-32D45EC7DB1C Q34467932-F2E462A2-8A95-4710-BA1B-A20975433063 Q34569181-3866346D-B525-4A8F-9F96-1125E44789B0 Q34622565-D160D9F9-EA4C-47C2-94AB-5FE51684B57C Q34929075-835B1E35-DE36-447C-B432-403C59B285AE Q35066533-46DB1BD6-BA8C-46ED-B2D1-79F1DBEC2DB4 Q35073445-E6D24E65-A685-4BD9-824C-192514470943 Q35644706-D9517B55-608A-4132-A2E6-C101E0DCD40F Q35668217-71C3260B-C479-47EB-A5A4-1AAE2D639D03 Q35802505-0A497504-AC67-4560-923D-295810D3FE62 Q35809479-7BFAA841-E3B3-4482-AE0D-FF1D22E50073 Q35868702-BD24D107-8FCB-4551-BA50-5CE277FC4832 Q36071760-CA126EC0-3777-4650-A287-F10CA114EC0A Q36109812-AA114705-F2E3-44CC-A556-DB0640C89F49 Q36190228-DE178E35-67AA-426B-95CB-88963241E1C6 Q36240034-03C07C47-2A52-4E12-94FF-1F95300C8162 Q36289709-0704C4F3-3565-4653-8F67-4FD9870F4EDD Q36311573-A124AED7-599B-40A0-9EA7-5B2D15D809CC Q36319941-2CE80EE3-D60A-4709-9740-FB9CECF1E4F9 Q36615291-D7C911EA-3919-4EFD-A035-B7BF8890B55E Q36616533-9E3873AC-CEA4-4D72-B09E-4D7C8EE99589 Q36679727-6C4FC6C5-32E2-4A52-B262-3F77FEFB0132 Q36695105-592F0DDC-4AB2-4894-9187-EC0EEBB2C745 Q36813303-1BA8687A-10A2-42A1-87FE-C862D57CCD52 Q36817519-1A6C3C01-7B15-4220-8F66-314D1FFA0D9A Q37133404-F8C680AA-5496-4DB0-93AC-E787DA7C56A2 Q37135912-F8F856D6-115B-4811-9C1A-3B7D3D3DE905 Q37188108-413743D3-3F0F-468D-8593-34B680B3C501 Q37189434-A90AA658-BAC0-42A7-B7DF-7F99F3600CB0 Q37302072-1BB204B9-C031-4FF4-A52C-7D671649EF61 Q37451826-44B5D050-0AF3-4B0C-9E32-54C642AF41D4 Q37604419-711169CA-121B-4FC0-8B7C-41B2FEFA3AF1

P2860

Inclusion of HPV testing in routine cervical cancer screening for women above 29 years in Germany: results for 8466 patients.

http://www.wikidata.org/entity/Q35138635

description

2003 nî lūn-bûn

@nan

2003 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2003 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2003年の論文

@ja

2003年論文

@yue

2003年論文

@zh-hant

2003年論文

@zh-hk

2003年論文

@zh-mo

2003年論文

@zh-tw

2003年论文

@wuu

name

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@ast

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@en

type

label

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@ast

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@en

prefLabel

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@ast

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@en

P1433

Q35138635-3A64DACB-079C-4FB0-8BCB-9958E236CBF2

P1476

Q35138635-066A2008-D7FB-4121-B3FA-590FDA12D078

P2093

Q35138635-08583237-C76D-40DA-9F74-FF44F9EAB17D

Q35138635-0A2A3FB0-F58B-455E-A7AC-0F22EC395CE5

Q35138635-0A73A6C2-5600-41EF-B353-C35CBE5FCAA3

Q35138635-2BA52677-70BF-41A1-B670-7DC98FC21CCE

Q35138635-3968092C-69AB-4C22-B11C-549D6F1172B4

Q35138635-5068F4EF-6C13-422A-BCF0-9D527C9FE78B

Q35138635-5B85FE10-8B1B-4E0F-B789-E23F518D00D6

Q35138635-78806832-CCCD-4D91-A74A-DF718F07D703

Q35138635-7E220498-8135-463B-9D76-86B56B47A4F7

Q35138635-A19553A3-5EE9-4496-8A50-8B76664AD703

P2860

Q35138635-2FB060B0-4D37-43CD-8119-E2CF9C5325D3

Q35138635-3487C9FF-2886-487A-B51A-3999012BFA77

Q35138635-60C1D7FE-496C-45A7-AFBC-15769EB1DF2B

Q35138635-80789BB5-B416-4563-96DF-9FCE323A21D5

Q35138635-8C46CFF3-441C-44F3-8296-203BE69D8C74

Q35138635-8C72D455-44D9-495C-B655-C3FA6AA3B584

Q35138635-9B5B6854-38FE-43D3-AD88-83414FE11253

Q35138635-A0213C07-846D-48DB-91D9-DA4CA1782AB5

Q35138635-B535115B-44D2-4F70-BC85-96B47357AAEA

Q35138635-E0A91A6B-41F8-4AC5-A003-C1F5C6A4F4E7

P2888

Q35138635-7900F825-46EF-480B-B32F-78C132572730

P304

Q35138635-3EC8E99B-835A-4ACD-BC3F-FFE97442EE75

P31

Q35138635-7209D51C-C743-4188-93F2-ABAC3C9C0FED

P356

Q35138635-8F33576A-E1AB-43B2-997A-CF2B21AD28B5

P407

Q35138635-0A9D332C-10ED-4EB4-B40E-0094A6E3E416

P433

Q35138635-9761526F-C24E-4F90-A88D-614B15594A55

P478

Q35138635-37D30CE9-558E-4F04-B178-1338C06A0F95

P577

Q35138635-3C17267E-F91C-45E9-8F67-416DDD74F658

P5875

Q35138635-55836D76-3BBF-402D-8E56-DE618ADF62A5

P6179

Q35138635-15A9B462-FD14-43AC-815D-6B83531F9E67

P698

Q35138635-C64FBB74-C84E-428E-9035-A67316D5684B

P921

Q35138635-B7B5E7B3-03C6-4E7D-B60E-83B120FDE22A

P932

Q35138635-98F4EA39-D186-4669-A89C-098DDF9D64D0

P356

P1433

British Journal of Cancer

P1476

Inclusion of HPV testing in ro ...... ny: results for 8466 patients.

@en

P2093

B Holz

http://www.w3.org/2001/XMLSchema#string

B Schopp

http://www.w3.org/2001/XMLSchema#string

E van den Akker

http://www.w3.org/2001/XMLSchema#string

F van Loenen-Frosch

http://www.w3.org/2001/XMLSchema#string

G Boehmer

http://www.w3.org/2001/XMLSchema#string

H de Carvalho Gomes

http://www.w3.org/2001/XMLSchema#string

K-U Petry

http://www.w3.org/2001/XMLSchema#string

M Menton

http://www.w3.org/2001/XMLSchema#string

P Davies

http://www.w3.org/2001/XMLSchema#string

S Garbrecht-Buettner

http://www.w3.org/2001/XMLSchema#string

P2860

Human papillomavirus is a necessary cause of invasive cervical cancer worldwide

Comparison of PCR- and hybrid capture-based human papillomavirus detection systems using multiple cervical specimen collection strategies.

Efficacy of cervical-smear collection devices: a systematic review and meta-analysis.

Comparison of human papillomavirus detection and typing by cycle sequencing, line blotting, and hybrid capture.

Nonisotopic detection of human papillomavirus DNA in clinical specimens using a consensus PCR and a generic probe mix in an enzyme-linked immunosorbent assay format

Screening for high-grade cervical intra-epithelial neoplasia and cancer by testing for high-risk HPV, routine cytology or colposcopy.

Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group.

PCR based high risk HPV testing is superior to neural network based screening for predicting incident CIN III in women with normal cytology and borderline changes.

HPV testing in primary screening of older women.

Human papillomavirus testing in primary screening for the detection of high-grade cervical lesions: a study of 7932 women

P2888

P304

1570-1577

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/SJ.BJC.6600918

http://www.w3.org/2001/XMLSchema#string

P407

P433

10

http://www.w3.org/2001/XMLSchema#string

P478

88

http://www.w3.org/2001/XMLSchema#string

P577

2003-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7129444

http://www.w3.org/2001/XMLSchema#string

P6179

1029090078

http://www.w3.org/2001/XMLSchema#string

P698

12771924

http://www.w3.org/2001/XMLSchema#string

P921

P932

2377109

http://www.w3.org/2001/XMLSchema#string